News

Filter

Current filters:

Array BioPharma

1 to 9 of 14 results

Array acquires worldwide rights to encorafenib from Novartis

Array acquires worldwide rights to encorafenib from Novartis

23-01-2015

Oncology specialist Array Biopharma has reached an agreement with Swiss drug major Novartis to acquire…

Array BioPharmaencorafenibLicensingNovartisOncologyPharmaceutical

Array BioPharma to regain global rights to binimetinib from Novartis

04-12-2014

Shares of US biotech firm Array BioPharma leapt 22.8% to $4.80 in after-hours trading on Wednesday, after…

Array BioPharmabinimetinibBiotechnologyGlobalLicensingNovartisOncology

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

ESMO 2014: Boehringer Ingelheim’s new data for afatinib and Array’s binimetinib

01-10-2014

German family-owned drug major Boehringer Ingelheim has presented new data at the annual congress of…

afatinibArray BioPharmabinimetinibBoehringer IngelheimGermanyOncologyPharmaceuticalResearch

Executive Q&A: Nicholas Saccomano, CSO of Array BioPharma

Executive Q&A: Nicholas Saccomano, CSO of Array BioPharma

15-07-2014

In an interview with The Pharma Letter, Nicholas Saccomano, chief science officer of Array BioPharma,…

Array BioPharmaBiogen IdecBiotechnologyChief science officerHealth Medical PharmaInterviewsMelanomaOncologyProtein kinase inhibitorUSA

Array BioPharma inks deal with Biogen Idec on autoimmune disorders

Array BioPharma inks deal with Biogen Idec on autoimmune disorders

30-05-2014

US biotech firms Array BioPharma and Biogen Idec have entered into a collaboration for the discovery…

Array BioPharmaBiogen IdecBiotechnologyImmunologicalsLicensingResearch

Array BioPharma signs up to $387 million deal

30-07-2013

In a second licensing deal this week US biotech major Celgene (Nasdaq: CELG) has entered into a strategic…

Array BioPharmaBiotechnologyCelgeneInflammatory diseasesLicensing

Shares jump as Array BioPharma reports positive results for asthma drug

23-07-2013

US biotech firm Array BioPharma (Nasdaq: ARRY) saw its shares jump as it announced that its drug candidate…

Array BioPharmaBiotechnologyNorth AmericaResearchRespiratory and Pulmonary

Start-up Loxo Oncology in deal with Array BioPharma

11-07-2013

Loxo Oncology, a biopharmaceutical company established and funded by Aisling Capital in May this year,…

Array BioPharmaBiotechnologyLicensingLoxo OncologyOncology

1 to 9 of 14 results

COMPANY SPOTLIGHT

Menarini

Back to top